Transient contribution of mast cells to pulmonary eosinophilia but not to hyper-responsiveness (Q43987760)

28 November 2017

title

Transient contribution of mast cells to pulmonary eosinophilia but not to hyper-responsiveness (English)

1 reference

28 November 2017

0 references

Ogawa K

1

1 reference

28 November 2017

Kaminuma O

2

1 reference

28 November 2017

Kikkawa H

3

1 reference

28 November 2017

Nakata A

4

1 reference

28 November 2017

Asahina M

5

1 reference

28 November 2017

Egan RW

6

1 reference

28 November 2017

Akiyama K

7

1 reference

28 November 2017

Mori A

8

1 reference

28 November 2017

publication date

1 January 2002

1 reference

Clinical & Experimental Allergy

28 November 2017

published in

1 reference

28 November 2017

volume

32

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

140-148

1 reference

T cells and eosinophils in the pathogenesis of asthma

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Recombinant human interleukin 5 is a selective activator of human eosinophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Interleukin 4 is localized to and released by human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Activated mast cells produce interleukin 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Attenuation of allergic airway inflammation in IL-4 deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Virgin T cells do not provide help for antigen-specific B cells in the absence of IL-4, IL-5, and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Evidence that cyclosporin A and dexamethasone inhibit allergic airway eosinophilic inflammation via suppression of interleukin-5 synthesis by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

The mechanism of action of cyclosporin A and FK506

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Mast cells as a source of multifunctional cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

The importance of leukotrienes in airway inflammation in a mouse model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

IL‐3 does not affect the allergic airway responses and leukotriene production after allergen challenge in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01248.X

10.1046/J.0022-0477.2001.01248.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference